期刊文献+

IL-12基因联合CD40L基因治疗小鼠黑色素瘤的实验研究 被引量:1

Studies on the effects of Combined IL-12 and CD40L gene therapy for murine melanoma
下载PDF
导出
摘要 目的:观察腺病毒介导的小鼠白细胞介素12基因(AdmIL-12)和CD40配体基因(AdmCD40L)对小鼠黑色素瘤的抗肿瘤效果。方法:利用B16细胞皮下注射C57BL/6小鼠建立小鼠黑色素瘤模型,单独或联合应用分别携带小鼠IL-12基因和CD40L基因的重组腺病毒进行直接瘤内注射治疗,观察小鼠皮下肿瘤生长及成活情况。采用乳酸脱氢酶释放法检测荷瘤小鼠脾细胞CTL活性变化。结果:AdmIL-12和AdmCD40L在体内外均能有效表达;AdmIL-12能显著抑制荷瘤小鼠皮下肿瘤的生长并明显延长其生存时间,能显著增强荷瘤小鼠的脾细胞CTL杀伤活性。AdmCD40L的抗瘤效果不明显,但与Ad-mIL-12联合应用可明显提高抗肿瘤效果。结论:腺病毒介导的mIL-12基因对小鼠黑色素瘤有显著的治疗效果,且与CD40L基因联合应用能进一步提高抗肿瘤效果。 Objective:To observe the therapeutic efficiency of adenovirus-mediated interleukin-12 gene(AdmIL-12) and CD40L ligand gene(AdmCD40L) intratumoral transfer in established murine melanoma in vivo. nethods:C57BL/6 mice were inoculated subcutaneously with B16 cells to establish the murine melanoma model. The tumor-bearing mice were injected intratumorally with murine IL-12 gene and CIMOL gene recombinant adenovirus. Tumor growth and the survival of tumor-bearing mice were observed. The CTL activity was measured in vitro by lactate dehydrogenase(LDH) release assay. Results:Both AdmIL-12 and AdmCD40L can be efficiently expressed in vitro and in vivo. The treatment with AdmIL-12 could significantly inhibit the tumor growth and prolong the survival period of the tumor-beraing mice. Splenic CTL activity of the mice was also enhanced after IL-12 gene transfer. But the anti-tumor effects of AdmCD40L gene were not significant. In contrast, Co-delivery of IL-12 gene and CD40L gene lead to stronger antitumor effects than IL-12 gene alone. Conclusion:Adenovirus-mediated interleukin-12 gene and CD40L ligand gene transfer together intratumorally has significant therapeutic effects on mice melanoma in vivo.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2007年第5期426-429,共4页 Chinese Journal of Immunology
基金 国家自然科学基金海外青年合作研究基金资助(30328011)
关键词 IL-12 CD40L 腺病毒载体 黑色素瘤 基因治疗 抗肿瘤作用 Interleukin-12 CD40L Adenovirus vector Melanoma Gene therapy Antitumor effect
  • 相关文献

参考文献13

  • 1Lamont A G,Adorini L.IL-12:a key cytokine in immune regulation[J].Immunol Today,1996; 17:214-217.
  • 2Marshall E.Cancer trial of interleukin-12 halted[J].Science,1995; 268:1555.
  • 3Caruso M,Pham-Nguyen K,Kwong Y L et al.Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma[J].Proc Natl Acad Sci USA,1996; 93(21):11302-11306.
  • 4Gambotto A,Tuting T,McVey D L et al.Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12[J].Cancer Gene Ther,1999; 6 (1):45-53.
  • 5Liu Y,Ehtesham M,Samoto K et al.In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma[J].Cancer Gene Ther,2002; 9(1):9-15.
  • 6Melero I,Mazzolini G,Narvaiza I et al.IL-12 gene therapy for cancer:in synergy with other immunotherapies[J].Trends Immunol,2001; 22(3):113-115.
  • 7Ulett G C,Ketheesan N,Hirst R G.Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei[J].Infect Immun,2000; 68 (4):2034-2042.
  • 8Heinzerling L,Dummer R,Pavlovic J et al.Tumor regression of human and murine melanoma after intratumoral injection of IL-12 encoding plasmid DNA in mice[J].Exp Dermatol,2002; 11 (3):232-240.
  • 9Grewal I S,Flavell R A.CD40 and CD154 in cell-mediated immunity[J].Annu Rev Immunol,1998; 16:111-135.
  • 10Tong A W,Stone M J.Prospects for CD40-directed experimental therapy of human cancer[J].Cancer Gene Ther,2003; 10(1):1-13.

同被引文献8

  • 1Kilinc MO, Aulakh KS, Nair RE, et al. Reversing tumor immune suppression with intratumoral II. 12.. Activation of tumor-associated T effector/memory cells, induction of T suppressor apotosis, and infiltration of CD8+ T effedctors [J]J Immunol, 2006, 177 (10): 6962-6973.
  • 2Portielje JE, Gratama JW, van Ojik H H, et al. IL-12: a promising adjuvant for cancer vaccination ~J]. Cancer Immu- nollmmun, 2003, 52 (03): 133-44.
  • 3Colombo MP, Trinchieri G. Interleukin-12 in anti-tumor immunity and immunotherapy [J]. Cytokine Growth Factor Rev. 2002, 13 (02).. 155-68.
  • 4Kanagawa N, Gao JQ, Motomura Y, et al. Anti-tumor mechanism of intratumoral injection with IL-12-expressing ade- noviral vector against IL-12-unresponsive tumor [J]. Biochem Biophys Res Commun, 2008, 372 (04): 821-825.
  • 5Wang S, Zheng Z, Weng Y, et al. Angiogenesis and anti-angiogenesis activity of Chinese medical herbal extracts EJ]. LifeSci, 2004, 74 (20): 2467-2478.
  • 6Waldmann TA. Effective cancer therapy through immunomodulation [J]. Annu Rev Med, 2006, 57:65-81.
  • 7Watkins SK, Egilrnez NK, Suttles J, et al. IL-12 rapidly alters the functional profile of tumor-associated and tumor-in- filtrating macrophages in vitro and in vivo [J]. J Imrnunol, 2007, 178 (03) .. 1357-62.
  • 8Cao X, Leonard K, Collins LI, et al. Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regu- latory T-cell proliferation and enhances tumor clearance [J] Cancer Res, 2009, 69 (22) .. 8700-8709.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部